CBD Vida, a startup based in Campinas, São Paulo, Brazil has become the first company with administrative headquarters in Brazil to market cannabidiol-based drugs with direct import through prescription and medical report.
The Brazilian national market for CBD is expected to turnover $4.7 billion in the next three years, according to researchers from BDS Analytics and Arcview Market Research.
Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 -- Click here to learn more!
Currently, 7,000 people are authorized by the Brazilian Health Regulatory Agency (ANVISA), an agency linked to the Ministry of Health, to import this type of medicine in Brazil.
For the company's CEO, Fabio Camata Candello, the moment is to invest in the Brazilian market.
"We are witnessing an expanding market and the business possibilities in CBD in Brazil are enormous. CBD Vida is a pioneer and we have a very important role in Brazilian society in providing high quality products," he said.
Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!